相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bladder Cancer Biomarkers: Review and Update
Soudeh Ghafouri-Fard et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma
Jehn-Chuan Lee et al.
CANCER LETTERS (2014)
Microtubules and actin crosstalk in cell migration and division
Tara Kafiyeh Akhshi et al.
CYTOSKELETON (2014)
Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation
Sara Monteiro-Reis et al.
EUROPEAN JOURNAL OF CANCER (2014)
E-cadherin gene promoter hypermethylation may contribute to the risk of bladder cancer among Asian populations
Gang Li et al.
GENE (2014)
Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways
Kun-Chun Chiang et al.
SCIENTIFIC REPORTS (2014)
The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer
Xingya Wang et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1
Klaus Unsicker et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression
Sung Un Kang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests
Steve Goodison et al.
MOLECULAR DIAGNOSIS & THERAPY (2013)
Overexpression of N-Myc Downstream-Regulated Gene 2 (NDRG2) Regulates the Proliferation and Invasion of Bladder Cancer Cells In Vitro and In Vivo
Ruixiao Li et al.
PLOS ONE (2013)
Metallothionein 3: An androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells
Horng-Heng Juang et al.
PROSTATE (2013)
Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development
Kaijie Wu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role?
Jill Corre et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Mechanisms by Which Interleukin-6 Attenuates Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells
Ke-Hung Tsui et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer
Niels Fristrup et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells
Li-Chuan Chung et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Macrophage Inhibitory Cytokine-1: A review of its pleiotropic actions in cancer
Yazan S. Khaled et al.
CANCER BIOMARKERS (2012)
Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells
Ke-Hung Tsui et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Growth/differentiation factor-15: prostate cancer suppressor or promoter?
P. Vanhara et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2012)
Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection
Mototsugu Muramaki et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Wild-Type p53 Attenuates Cancer Cell Motility by Inducing Growth Differentiation Factor-15 Expression
Jung-Chien Cheng et al.
ENDOCRINOLOGY (2011)
Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples
Vera L. Costa et al.
CLINICAL CANCER RESEARCH (2010)
GDF-15 Contributes to Proliferation and Immune Escape of Malignant Gliomas
Patrick Roth et al.
CLINICAL CANCER RESEARCH (2010)
The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications
Veerle Melotte et al.
FASEB JOURNAL (2010)
Loss of GDF-15 abolishes Sulindac chemoprevention in the Apc(Min/+) mouse model of intestinal cancer
Teresa A. Zimmers et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Divergent Molecular Mechanisms Underlying the Pleiotropic Functions of Macrophage Inhibitory Cytokine-1 in Cancer
Murielle Mimeault et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Cadherin Switching and Bladder Cancer
Richard T. Bryan et al.
JOURNAL OF UROLOGY (2010)
Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression
David J. McConkey et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Molecular Pathogenesis and Diagnostics of Bladder Cancer
Anirban P. Mitra et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome
Sophie Shnaper et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis
Teresa A. Zimmers et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States
Alan R. Schned et al.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY (2008)
Clinical relevance of maspin expression in bladder cancer
Wolf-D. Beecken et al.
WORLD JOURNAL OF UROLOGY (2006)
Targeted molecular therapy of anaplastic thyroid carcinoma with AEE788
S Kim et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
